Corcel - Cessation of Coverage

Cessation of Coverage


Align Research is ceasing coverage on Corcel with immediate effect. Please note you should no longer rely on any previous research or estimates for this company. 


    A director of Align Research owns shares in Corcel. Catalyse Capital Limited, which shares a common director with Align Research, also owns shares in Corcel. Full details of our Company & Personal Account Dealing Policy can be found on our website 

    For full disclaimer information please refer to the last page of the full document. This investment may not be suitable for your personal circumstances. If you are in any doubt as to its suitability you should seek professional advice. This note does not constitute advice and your capital is at risk. This is a marketing communication and cannot be considered independent research.

Table: financial overview
Year to June 2020A 2021A
Revenue (£’000) - -
Pre tax (£'000) (1,482) (1,227)
EPS (p) (2) (1)
Source: Company accounts